Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Bristol Myers bags FDA nod to bring CAR-T to CLL
BMS' Breyanzi, a one-time CAR-T therapy, will compete with Eli Lilly's Jaypirca, a chronic oral drug, in CLL following BTK and BCL-2 inhibitors.
Angus Liu
Mar 15, 2024 9:46am
BeiGene finally snags FDA approval for PD-1 drug Tevimbra
Mar 15, 2024 8:39am
FDA approves first drug for MASH in Madrigal's Rezdiffra
Mar 14, 2024 3:56pm
BMS, overshadowed by ADC rival, wins FDA nod in 1L bladder cancer
Mar 8, 2024 9:56am
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Mar 6, 2024 9:52am